Wound Care - Serbia

  • Serbia
  • Revenue in the Wound Care market amounts to US$2.17m in 2024. The market is expected to grow annually by 1.17% (CAGR 2024-2029).
  • In global comparison, most revenue is generated in the United States (US$1,052m in 2024).
  • In relation to total population figures, per person revenues of US$0.31 are generated in 2024.

Key regions: Philippines, India, Europe, United States, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care market in Serbia has been experiencing steady growth in recent years, driven by increasing customer preferences for advanced wound care products and treatments. With a growing elderly population and a higher incidence of chronic diseases, the demand for wound care products and services has been on the rise. Additionally, the increasing awareness about the importance of wound care and the availability of innovative products have also contributed to the market's development.

Customer preferences:
Customers in Serbia are increasingly opting for advanced wound care products and treatments. This shift in preference can be attributed to the rising awareness about the benefits of advanced wound care in promoting faster healing and reducing the risk of complications. Customers are willing to invest in products that offer better outcomes and improved quality of life. As a result, there has been a growing demand for products such as wound dressings, wound closure devices, and wound healing agents.

Trends in the market:
One of the key trends in the Wound Care market in Serbia is the increasing adoption of advanced wound dressings. These dressings are designed to provide optimal moisture balance, promote faster healing, and reduce the risk of infection. Customers are gravitating towards these products due to their convenience and effectiveness in managing various types of wounds, including chronic and acute wounds. Another trend in the market is the growing popularity of wound healing agents, such as growth factors and bioactive dressings. These products stimulate the natural healing process and enhance tissue regeneration. Customers are increasingly seeking these advanced solutions to accelerate the healing of chronic wounds and improve overall wound care outcomes.

Local special circumstances:
Serbia has a rapidly aging population, which has contributed to the increased demand for wound care products and services. As people age, they become more susceptible to chronic wounds, such as pressure ulcers and diabetic foot ulcers. This demographic trend has created a significant market opportunity for wound care providers in Serbia. Furthermore, the prevalence of chronic diseases, such as diabetes and cardiovascular diseases, is on the rise in Serbia. These conditions often lead to complications that require specialized wound care. As a result, there is a growing need for advanced wound care products and services to manage these conditions effectively.

Underlying macroeconomic factors:
The economic growth in Serbia has had a positive impact on the healthcare sector, including the wound care market. The increasing disposable income and improved access to healthcare services have allowed more people to seek advanced wound care treatments. Additionally, the government's focus on improving healthcare infrastructure and promoting medical tourism has also contributed to the market's development. In conclusion, the Wound Care market in Serbia is experiencing growth due to customer preferences for advanced wound care products and treatments. The increasing awareness about the benefits of advanced wound care, the growing elderly population, and the rising prevalence of chronic diseases are key drivers of this market development. As the market continues to evolve, there will be opportunities for companies to introduce innovative products and services to meet the growing demand for effective wound care solutions in Serbia.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)